Literature DB >> 16541148

Assessment of real-time PCR for diagnosis of Mycoplasma pneumoniae pneumonia in pediatric patients.

Miyuki Morozumi1, Akira Ito, Somay Y Murayama, Keiko Hasegawa, Reiko Kobayashi, Satoshi Iwata, Naohisa Kawamura, Haruo Kuroki, Eiichi Nakayama, Takeshi Tajima, Kimiko Ubukata.   

Abstract

We developed a real-time PCR to detect Mycoplasma pneumoniae with a primer set designed for the 16S rRNA gene. Clinical samples (n=937) were collected from children with community-acquired pneumonia between April 2002 and March 2004 at 12 Japanese medical institutions. Sensitivity of real-time PCR was calculated as 10 colony-forming units per reaction tube using a pMP01 plasmid carrying a 225-bp target DNA fragment of the 16S rRNA gene in M. pneumoniae M129, a standard strain. Results, obtained within 2 h, were compared with those of conventional culture and serologic methods. Of all cases tested, 151 (16.4%) and 129 (13.8%) were positive for M. pneumoniae by real-time PCR and by culture, respectively. Among the 151 cases, almost all of those tested serologically by passive agglutination showed a rise in M. pneumoniae antibody titre between acute and convalescent sera. We conclude that this real-time PCR can identify M. pneumoniae rapidly and fulfills the need for rapid identification, high sensitivity, and high specificity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16541148     DOI: 10.1139/w05-118

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  9 in total

1.  Microfluidic platform versus conventional real-time polymerase chain reaction for the detection of Mycoplasma pneumoniae in respiratory specimens.

Authors:  Elizabeth Wulff-Burchfield; Wiley A Schell; Allen E Eckhardt; Michael G Pollack; Zhishan Hua; Jeremy L Rouse; Vamsee K Pamula; Vijay Srinivasan; Jonathan L Benton; Barbara D Alexander; David A Wilfret; Monica Kraft; Charles B Cairns; John R Perfect; Thomas G Mitchell
Journal:  Diagn Microbiol Infect Dis       Date:  2010-03-12       Impact factor: 2.803

2.  Comparison of the illumigene Mycoplasma DNA amplification assay and culture for detection of Mycoplasma pneumoniae.

Authors:  Amy E Ratliff; Lynn B Duffy; Ken B Waites
Journal:  J Clin Microbiol       Date:  2014-01-15       Impact factor: 5.948

3.  Difference of clinical features in childhood Mycoplasma pneumoniae pneumonia.

Authors:  You-Sook Youn; Kyung-Yil Lee; Ja-Young Hwang; Jung-Woo Rhim; Jin-Han Kang; Joon-Sung Lee; Ji-Chang Kim
Journal:  BMC Pediatr       Date:  2010-07-06       Impact factor: 2.125

Review 4.  New diagnostic tests for pneumonia: what is their role in clinical practice?

Authors:  Thomas M File
Journal:  Clin Chest Med       Date:  2011-07-12       Impact factor: 2.878

5.  Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection.

Authors:  Anna C Nilsson; Per Björkman; Kenneth Persson
Journal:  BMC Microbiol       Date:  2008-06-11       Impact factor: 3.605

6.  Rapid optimization of antimicrobial chemotherapy given to pediatric patients with community-acquired pneumonia using PCR techniques with serology and standard culture.

Authors:  Eiichi Nakayama; Keiko Hasegawa; Miyuki Morozumi; Reiko Kobayashi; Naoko Chiba; Taketoshi Iitsuka; Takeshi Tajima; Keisuke Sunakawa; Kimiko Ubukata
Journal:  J Infect Chemother       Date:  2007-10-30       Impact factor: 2.211

Review 7.  What is the role of newer molecular tests in the management of CAP?

Authors:  Charlotte A Gaydos
Journal:  Infect Dis Clin North Am       Date:  2013-03       Impact factor: 5.982

8.  Immunochromatography for the diagnosis of Mycoplasma pneumoniae infection: A systematic review and meta-analysis.

Authors:  Seo Hee Yoon; In Kyung Min; Jong Gyun Ahn
Journal:  PLoS One       Date:  2020-03-17       Impact factor: 3.240

9.  Clinical significance of different bacterial load of Mycoplasma pneumoniae in patients with Mycoplasma pneumoniae pneumonia.

Authors:  Wujun Jiang; Yongdong Yan; Wei Ji; Yuqing Wang; Zhengrong Chen
Journal:  Braz J Infect Dis       Date:  2013-10-26       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.